caffeine has been researched along with Cardiomyopathies, Primary in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LaRue, S | 1 |
| Shanks, A | 1 |
| Wang, IW | 1 |
| Ewald, G | 1 |
| Anderson, D | 1 |
| Joseph, S | 1 |
| Okafor, C | 1 |
| Liao, R | 1 |
| Perreault-Micale, C | 1 |
| Li, X | 1 |
| Ito, T | 1 |
| Stepanek, A | 1 |
| Doye, A | 1 |
| de Tombe, P | 1 |
| Gwathmey, JK | 1 |
| Kannankeril, PJ | 1 |
| Mitchell, BM | 1 |
| Goonasekera, SA | 1 |
| Chelu, MG | 1 |
| Zhang, W | 1 |
| Sood, S | 1 |
| Kearney, DL | 1 |
| Danila, CI | 1 |
| De Biasi, M | 1 |
| Wehrens, XH | 1 |
| Pautler, RG | 1 |
| Roden, DM | 1 |
| Taffet, GE | 1 |
| Dirksen, RT | 1 |
| Anderson, ME | 1 |
| Hamilton, SL | 1 |
| Yaras, N | 1 |
| Bilginoglu, A | 1 |
| Vassort, G | 1 |
| Turan, B | 1 |
| Henry, JP | 1 |
| Stephens, PM | 1 |
| Mambo, NC | 1 |
| Silver, MD | 1 |
| McLaughlin, PR | 1 |
| Huckell, VF | 1 |
| McEwan, PM | 1 |
| Britt, BA | 1 |
| Morch, JE | 1 |
| Hatem, SN | 1 |
| Sham, JS | 1 |
| Morad, M | 1 |
| Pessah, IN | 1 |
| Durie, EL | 1 |
| Schiedt, MJ | 1 |
| Zimanyi, I | 1 |
| Pretorius, PJ | 1 |
| Malan, NT | 1 |
9 other studies available for caffeine and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Left ventricular assist device in pregnancy.
Topics: Adolescent; Anticoagulants; Betamethasone; Bradycardia; Caffeine; Cardiomyopathies; Cesarean Section | 2011 |
Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine.
Topics: Ca(2+) Mg(2+)-ATPase; Caffeine; Calcium; Cardiomyopathies; Cardiotonic Agents; Heart; Heart Ventricl | 2003 |
Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.
Topics: Animals; Caffeine; Cardiomyopathies; Catecholamines; Central Nervous System Stimulants; Epinephrine; | 2006 |
Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Caffeine; Calc | 2007 |
Caffeine, stress, and cardiomyopathy.
Topics: Animals; Arousal; Caffeine; Cardiomyopathies; Death, Sudden; Humans; Mice; Smoking; Stress, Psycholo | 1983 |
Malignant hyperthermia susceptibility. A light and electron microscopic study of endomyocardial biopsy specimens from nine patients.
Topics: Adolescent; Adult; Caffeine; Cardiomyopathies; Female; Halothane; Heart Diseases; Humans; Male; Mali | 1980 |
Enhanced Na(+)-Ca2+ exchange activity in cardiomyopathic Syrian hamster.
Topics: Animals; Caffeine; Calcium; Cardiomyopathies; Carrier Proteins; Cricetinae; Electrophysiology; Intra | 1994 |
Anthraquinone-sensitized Ca2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy.
Topics: Alkaloids; Animals; Anthraquinones; Binding, Competitive; Caffeine; Calcium; Calcium Channels; Cardi | 1990 |
Factors affecting calcium transport by cardiac sarcoplasmic reticulum.
Topics: Animals; Biological Transport; Caffeine; Calcium; Cardiomyopathies; Cyclic AMP; Lanthanum; Myocardiu | 1974 |